Literature DB >> 6284644

Role of macrophage oxidative metabolism in resistance to vesicular stomatitis virus infection.

B Rager-Zisman, M Kunkel, Y Tanaka, B R Bloom.   

Abstract

The role of oxygen metabolites in mediating virucidal activity was studied in two cloned macrophage-like cell lines. The parental cell line, J774.16, upon appropriate stimulation with either phorbol myristate acetate (PMA) or aggregated immunoglobulin, is induced to oxidize glucose via the hexose monophosphate shunt and produce O2- and H2O2. A variant derived from it, clone C3C, is defective in oxidative metabolism and cannot be stimulated to produce O2- or H2O2. Significant differences in yields of vesicular stomatitis virus (VSV) between stimulated clone 16 cells and unstimulated cells could be obtained only when low multiplicities were used for infection. Under the same conditions, PMA stimulation of the variant clone C3C produced no reduction in yields. The effect of PMA on virus yields in clone 16 was short-lived and dose dependent. PMA stimulation of either cell line had no effect on the number of infectious centers, suggesting that the antiviral effect was likely to be an extracellular, rather than an intracellular, one. Using glucose oxidase plus aglucose to generate H2O2 in solution, we observed that H2O2 alone is capable of killing limited amounts of VSV. The inactivation of VSV, both by H2O2 in solution and by activated clone 16 cells, could be inhibited by catalase. We conclude that intracellular resistance to VSV is primarily mediated through nonoxidative mechanisms, since activated macrophages can kill only a limited number of infectious virus particles extracellularly by means of secreted H2O2.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284644      PMCID: PMC551461          DOI: 10.1128/iai.36.3.1229-1237.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

2.  Role of macrophages and antibody in resistance of mice against yellow fever virus.

Authors:  B Zisman; E F Wheelock; A C Allison
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

Review 3.  Macrophages and viral immunity.

Authors:  S Silverstein
Journal:  Semin Hematol       Date:  1970-04       Impact factor: 3.851

4.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

5.  Transfer of interferon-producing macrophages: new approach to viral chemotherapy.

Authors:  L A Glasgow
Journal:  Science       Date:  1970-11-20       Impact factor: 47.728

6.  Peroxidase-mediated virucidal systems.

Authors:  M E Belding; S J Klebanoff; C G Ray
Journal:  Science       Date:  1970-01-09       Impact factor: 47.728

Review 7.  Disorders of phagocytic cell function.

Authors:  D G Nathan; R L Baehner
Journal:  Prog Hematol       Date:  1971

8.  A useful quantitative semimicromethod for viral plaque assay.

Authors:  B Rager-Zisman; T C Merigan
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

9.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

10.  The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.

Authors:  M Nowakowski; J D Feldman; S Kano; B R Bloom
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

2.  Structure-dependent antiviral activity of catechol derivatives in pyroligneous acid against the encephalomycarditis virus.

Authors:  Ruibo Li; Ryo Narita; Ryota Ouda; Chihiro Kimura; Hiroshi Nishimura; Mitsuyoshi Yatagai; Takashi Fujita; Takashi Watanabe
Journal:  RSC Adv       Date:  2018-10-22       Impact factor: 4.036

Review 3.  The potential use of liposome-mediated antiviral therapy.

Authors:  W C Koff; I J Fidler
Journal:  Antiviral Res       Date:  1985-06       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.